GlassScriptPhysician profile
Steven M Newman
NPI 1033187695
$2,417.55
in general payments reported to CMS, 2019-2025
18 companies · $588 in 2025
The $588 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $156 · 2021: $84.75 · 2022: $394 · 2023: $471 · 2024: $466 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,524.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $340.76 | 2023-2025 | Infuse, Miebo, Xiidra |
| Abbvie INC. | $275.72 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $255.43 | 2021-2025 | Acthar |
| Johnson & Johnson Vision Care, INC. | $236.70 | 2023-2024 | Acuvue |
| Alcon Vision LLC | $235.40 | 2022-2025 | Rocklatan, Simbrinza |
| New World Medical,INC. | $166.37 | 2022 | |
| Amgen INC. | $145.25 | 2025 | Tepezza |
| Ivantis, INC | $136.84 | 2020 | |
| Horizon Therapeutics Plc | $120.89 | 2022 | |
| Glaukos Corporation | $118.77 | 2023 | |
| Allergan, INC. | $105.64 | 2019-2021 | |
| Optos, INC. | $96.78 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $74.45 | 2019 | |
| Harrow Eye, LLC | $28.73 | 2025 | Vevye |
| Aerie Pharmaceuticals, INC. | $24.69 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $21.35 | 2019 | |
| Ge Healthcare | $16.96 | 2021 | |
| Thea Pharma INC. | $16.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.